(Q54464685)

English

The induction of specific antitumor immunity by in vivo treatment with interleukin-1 and sonicated tumor extract in a murine model.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/7919743

The induction of specific antitumor immunity by in vivo treatment with interleukin-1 and sonicated tumor extract in a murine model. (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/7919743

0 references

author name string

T Harada

1

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/7919743

N Kan

2

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/7919743

T Okino

3

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/7919743

Y Ichinose

4

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/7919743

Y Moriguchi

5

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/7919743

L Li

6

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/7919743

T Sugie

7

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/7919743

K Ohgaki

8

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/7919743

M Imamura

9

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/7919743

publication date

1 January 1994

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/7919743

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/7919743

24

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/7919743

6

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/7919743

561-563

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/7919743

Interleukin 1 as an adjuvant for active specific immunotherapy in a murine tumor model

1 reference

https://pubmed.ncbi.nlm.nih.gov/7919743

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Active specific immunotherapy with Newcastle-disease-virus-modified autologous tumor cells following resection of liver metastases in colorectal cancer. First evaluation of clinical response of a phase II-trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/7919743

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antitumor and therapeutic effects of spleen cells from tumor-bearing mice cultured with T cell growth factor and soluble tumor extract

1 reference

https://pubmed.ncbi.nlm.nih.gov/7919743

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Site-specific mutagenesis of the human interleukin-1 beta gene: structure-function analysis of the cysteine residues

1 reference

https://pubmed.ncbi.nlm.nih.gov/7919743

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-1 and its biologically related cytokines

1 reference

https://pubmed.ncbi.nlm.nih.gov/7919743

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Renal cell carcinoma treated by vaccines for active specific immunotherapy: correlation of survival with skin testing by autologous tumor cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/7919743

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II study on the postsurgical management of Stage II malignant melanoma with a Newcastle disease virus oncolysate

1 reference

https://pubmed.ncbi.nlm.nih.gov/7919743

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospectively randomized trial of adjuvant active-specific immunotherapy for human colorectal cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7919743

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Breast cancer-specific immunity evaluated by a new in vitro method--IL-2 enhanced MLTR]

1 reference

https://pubmed.ncbi.nlm.nih.gov/7919743

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

There is more than one interleukin 1.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7919743

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF01884580

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/7919743

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/7919743

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54464685&oldid=1388050936"